SPSIP Block and Opioid Use After MICS
SPSIPB-MICS
Evaluation of the Effectiveness of Serratus Posterior Superior Intercostal Plane Block in Perioperative Pain Management in Patients Undergoing Minimally Invasive Cardiac Surgery
1 other identifier
interventional
50
1 country
1
Brief Summary
This prospective, randomized, controlled, single-center clinical study aims to evaluate the effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in perioperative pain management among patients undergoing minimally invasive cardiac surgery (MICS). A total of 50 patients undergoing MICS will be randomized into two groups: one receiving standard analgesia plus ultrasound-guided SPSIPB with 30 mL of 0.25% bupivacaine, and a control group receiving standard analgesia only. The primary outcome is total postoperative opioid consumption within 24 hours. Secondary outcomes include postoperative pain scores, extubation time, block-related complications, and recovery parameters such as early mobilization, oral intake, Modified radiological atelectasis score and Quality of Recovery-15 scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2025
CompletedFirst Posted
Study publicly available on registry
December 2, 2025
CompletedStudy Start
First participant enrolled
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2026
CompletedApril 24, 2026
January 1, 2026
3 months
November 21, 2025
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total opioid consumption within 24 hours after surgery
The total amount of opioids (converted to intravenous morphine equivalent, mg) administered during the first 24 postoperative hours will be recorded from the patient-controlled analgesia (PCA) device and rescue analgesic doses.
24 hours postoperatively
Secondary Outcomes (7)
Postoperative pain scores (NRS)
6, 12, and 24 hours postoperatively
Extubation time
Immediate postoperative period
Intraoperative opioid consumption
During surgery
Block-related complications
Within 24 hours postoperatively
Postoperative recovery parameters
Within 48 hours postoperatively
- +2 more secondary outcomes
Study Arms (2)
SPSIPB Group
EXPERIMENTALPatients in this group will receive ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB) with 30 mL of 0.25% bupivacaine in addition to standard anesthesia and analgesia.
Sham Block Group
SHAM COMPARATORPatients in this group will undergo the same ultrasound-guided block procedure using identical technique and needle placement, but 30 mL of normal saline will be injected instead of local anesthetic. All other anesthesia and analgesia protocols will be identical to the experimental group.
Interventions
The same ultrasound-guided procedure will be performed using identical technique and needle placement, but 30 mL of normal saline will be injected instead of local anesthetic. This sham block will be performed to maintain blinding, while all other anesthesia and analgesia protocols will be identical to the experimental group.
The SPSIPB will be performed under ultrasound guidance using an in-plane technique. The needle will be advanced into the fascial plane between the serratus posterior superior and intercostal muscles at the 2nd-3rd intercostal level, and 30 mL of 0.25% bupivacaine will be injected unilaterally on the surgical side. This procedure will be applied in addition to standard anesthesia and analgesia.
Eligibility Criteria
You may qualify if:
- Patients scheduled for elective minimally invasive cardiac surgery (MICS)
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) physical status II-III
- Body mass index (BMI) between 18 and 35 kg/m²
- Patients who provide written informed consent for participation
You may not qualify if:
- Known allergy or hypersensitivity to local anesthetics
- Coagulopathy or current anticoagulant therapy
- Pregnancy or breastfeeding
- Impaired consciousness or inability to communicate
- Failed or technically inadequate block
- Refusal to undergo the block procedure
- Cognitive or mental disorders preventing valid pain assessment
- Opioid intolerance or contraindication to opioid use
- Development of intraoperative or postoperative complications requiring reoperation, prolonged mechanical ventilation, or intensive care
- Incomplete postoperative data or patient withdrawal from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
Related Publications (5)
Turan EI, Isik S, Baydemir AE, Sahin AS. Serratus posterior superior intercostal plane block for postoperative analgesia in clavicle surgeries: new indications for a novel block. Minerva Anestesiol. 2024 Nov;90(11):1058-1060. doi: 10.23736/S0375-9393.24.18275-2. Epub 2024 Aug 5. No abstract available.
PMID: 39101308BACKGROUNDAvci O, Gundogdu O, Balci F, Tekcan MN, Ozbey M. Efficacy of serratus posterior superior intercostal plane block (SPSIPB) on post-operative pain and total analgesic consumption in patients undergoing video-assisted thoracoscopic surgery (VATS): A double-blinded randomised controlled trial. Indian J Anaesth. 2023 Dec;67(12):1116-1122. doi: 10.4103/ija.ija_589_23. Epub 2023 Dec 13.
PMID: 38343684BACKGROUNDShimizu C, Wakimoto M, Kita T. Efficacy of epidural anesthesia in minimally invasive cardiac surgery. Saudi J Anaesth. 2024 Oct-Dec;18(4):528-533. doi: 10.4103/sja.sja_334_24. Epub 2024 Oct 2.
PMID: 39600439BACKGROUNDDost B, Turunc E, Aydin ME, Kaya C, Aykut A, Demir ZA, Narayanan M, De Cassai A. Pain Management in Minimally Invasive Cardiac Surgery: A Review of Current Clinical Evidence. Pain Ther. 2025 Jun;14(3):913-930. doi: 10.1007/s40122-025-00739-1. Epub 2025 Apr 24.
PMID: 40272720BACKGROUNDPiekarski F, Rohner M, Monsefi N, Bakhtiary F, Velten M. Anesthesia for Minimal Invasive Cardiac Surgery: The Bonn Heart Center Protocol. J Clin Med. 2024 Jul 5;13(13):3939. doi: 10.3390/jcm13133939.
PMID: 38999504BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zeliha A Demir, M.D.
Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation, Professor of Aneshesiology
- STUDY DIRECTOR
Aslıhan Aykut, M.D.
Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation, Associate Professor of Anesthesiology
- STUDY CHAIR
Nisan Özsan, M.D.
Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The anesthesiologist performing the block will be aware of group allocation, while the patients and the anesthesiologist responsible for postoperative data collection will remain blinded to the intervention. Pain assessments and other outcome measurements will be conducted by a blinded senior anesthesia resident who is unaware of which treatment each patient received.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 21, 2025
First Posted
December 2, 2025
Study Start
January 22, 2026
Primary Completion
April 15, 2026
Study Completion
April 22, 2026
Last Updated
April 24, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
This is a single-center academic study. Individual participant data will not be shared publicly. Aggregate results will be reported in publication.